PGC-1 coactivators in photoreceptor development and survival
PGC-1 coactivators in photoreceptor development and survival
批准号:
8561075
负责人:
Zoltan P Arany
金额:
$57.5万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-08-01 至 2014-07-31
关键词:
AcuteAdenovirusesAdultAerobicAllelesBiogenesisBiological AssayBiologyBlindnessCell Culture TechniquesCell RespirationCell SurvivalCellsCollaborationsDataDevelopmentDiseaseElectron MicroscopyElectroporationElectroretinographyEquilibriumEvaluationEyeFluorescenceFundus photographyGene DeliveryGene ExpressionGeneticGenetic ModelsGenus HippocampusHarvestHydrogen PeroxideInjection of therapeutic agentLeadLightMeasuresMediatingMetabolicMetabolismMitochondriaModelingMonitorMusOpticsOxidative StressPhotoreceptorsPlasmidsProductionReactive Oxygen SpeciesRespirationRetinaRetinalRoleSaintsSourceTestingTherapeutic InterventionTissuesVisionWorkX-Ray Computed Tomographyfallsin vivolight microscopyloss of functionmouse modelnoveloverexpressionoxidative damagephotoreceptor degenerationpreventprogramspublic health relevancerecombinaseresponsesuccesstherapeutic target
中文摘要
总结
光感受器(PR)退化是全球失明的主要原因,
仍然知之甚少。PR退化的主要原因被认为是
由活性氧(ROS)引起的损伤。公关也是一些最
高代谢细胞在体内,这种高有氧代谢是一个强大的
ROS的来源PR如何发展如此高的有氧能力,以及PR如何平衡
这种具有过量ROS的能力是未知的。我们在这里提出测试的假设
1)PR线粒体代谢的显著发育增加,
在出生后的发展是由转录辅激活因子PGC介导的,
1 α和β,已知其他线粒体代谢的有效调节剂,
PGC-1 α和β同时调节抗ROS程序,
可以用来减缓PR退化我们将用新的方法来检验这些假设。
遗传小鼠模型,并与国家的最先进的方法,基因传递到
眼睛这些研究的成功可能为治疗性干预开辟新的途径,
这些毁灭性的疾病。
英文摘要
SUMMARY
Photoreceptor (PR) degeneration is a leading cause of blindness worldwide, and
remains poorly understood. A leading cause of PR degeneration is thought to be
damage instilled by reactive oxygen species (ROS). PRs are also some of the most
highly metabolic cells in the body, and this high aerobic metabolism is a strong
source of ROS. How PRs develop such high aerobic capacity, and how PRs balance
this capacity with excess ROS, is not known. We propose here to test the hypotheses
that 1) the dramatic developmental increase in PR mitochondrial metabolism seen
during post-natal development is mediated by the transcriptional coactivators PGC-
1alpha and beta, known potent regulators of mitochondrial metabolism in other
cells; and 2) PGC-1alpha and beta simultaneously regulate an anti-ROS program that
can be usurped to slow PR degeneration. We will test these hypotheses with novel
genetic mouse models, and with state-of-the-art approaches for gene delivery to the
eye. Success in these studies may open new avenues for therapeutic intervention in
these devastating diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Acetate and Endothelial Pathobiology
-
批准号:10736268
-
项目类别:
-
资助金额:$74.24万
-
财政年份:2023
-
负责人:Zoltan P Arany
-
依托单位:
Comprehensive quantification of fuel use in cold-induced thermogenesis in vivo
-
批准号:10637680
-
项目类别:
-
资助金额:$57.23万
-
财政年份:2023
-
负责人:Zoltan P Arany
-
依托单位:
High-throughput screening for modulators of vascular fat transport to treat and prevent diabetes
-
批准号:10343859
-
项目类别:
-
资助金额:$65.58万
-
财政年份:2021
-
负责人:Zoltan P Arany
-
依托单位:
High-throughput screening for modulators of vascular fat transport to treat and prevent diabetes
-
批准号:10331230
-
项目类别:
-
资助金额:$66.13万
-
财政年份:2021
-
负责人:Zoltan P Arany
-
依托单位:
Branched chain amino acids and pancreatic cancer
-
批准号:10436144
-
项目类别:
-
资助金额:$45.59万
-
财政年份:2020
-
负责人:Zoltan P Arany
-
依托单位:
Branched chain amino acids in heart failure
-
批准号:10371891
-
项目类别:
-
资助金额:$58.31万
-
财政年份:2020
-
负责人:Zoltan P Arany
-
依托单位:
Branched chain amino acids in heart failure
-
批准号:9977599
-
项目类别:
-
资助金额:$58.13万
-
财政年份:2020
-
负责人:Zoltan P Arany
-
依托单位:
Branched chain amino acids in heart failure
-
批准号:10599927
-
项目类别:
-
资助金额:$58.31万
-
财政年份:2020
-
负责人:Zoltan P Arany
-
依托单位:
Branched chain amino acids and pancreatic cancer
-
批准号:10688001
-
项目类别:
-
资助金额:$45.59万
-
财政年份:2020
-
负责人:Zoltan P Arany
-
依托单位:
Keeping fat out of muscle - Role of Branched Amino Acids
-
批准号:10186735
-
项目类别:
-
资助金额:$47.61万
-
财政年份:2018
-
负责人:Zoltan P Arany
-
依托单位:
Keeping fat out of muscle - Role of Branched Amino AcidsAmino Acids in Insulin Resistance
-
批准号:10736605
-
项目类别:
-
资助金额:$57.31万
-
财政年份:2018
-
负责人:Zoltan P Arany
-
依托单位:
Selective mTORC1 inhibition to prevent and treat NAFLD and NASH
-
批准号:10298388
-
项目类别:
-
资助金额:$48.48万
-
财政年份:2016
-
负责人:Zoltan P Arany
-
依托单位:
sFlt and Metabolic Mechanisms of Peripartium Cardiomyopathy
-
批准号:9029058
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2016
-
负责人:Zoltan P Arany
-
依托单位:
Selective mTORC1 inhibition to prevent and treat NAFLD and NASH
-
批准号:10470224
-
项目类别:
-
资助金额:$48.48万
-
财政年份:2016
-
负责人:Zoltan P Arany
-
依托单位:
Selective mTORC1 inhibition to prevent and treat NAFLD and NASH
-
批准号:10627314
-
项目类别:
-
资助金额:$39.12万
-
财政年份:2016
-
负责人:Zoltan P Arany
-
依托单位:
sFlt and Metabolic Mechanisms of Peripartium Cardiomyopathy
-
批准号:9338286
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2016
-
负责人:Zoltan P Arany
-
依托单位:
Selective mTORC1 inhibition to prevent and treat NAFLD and NASH
-
批准号:10623345
-
项目类别:
-
资助金额:$48.48万
-
财政年份:2016
-
负责人:Zoltan P Arany
-
依托单位:
PGC-1 coactivators in photoreceptor development and survival
-
批准号:8706881
-
项目类别:
-
资助金额:$53.57万
-
财政年份:2013
-
负责人:Zoltan P Arany
-
依托单位:
Building Vascularized Skeletal Muscle for Tissue Engineering/Regeneration
-
批准号:8511263
-
项目类别:
-
资助金额:$24.12万
-
财政年份:2013
-
负责人:Zoltan P Arany
-
依托单位:
Building Vascularized Skeletal Muscle for Tissue Engineering/Regeneration
-
批准号:8628743
-
项目类别:
-
资助金额:$18.57万
-
财政年份:2013
-
负责人:Zoltan P Arany
-
依托单位:
海外基金